Aids Malignancy Consortium

This phase 1 trial is testing a CAR-T cell therapy (axicabtagene ciloleucel) in 20 adults with HIV and aggressive B-cell non-Hodgkin lymphoma that has come back or not responded to treatment. The therapy uses a patient's own immune cells, modified to recognize and attack cancer c…

This study tests a drug called ixazomib in 41 people with Kaposi sarcoma, a type of skin cancer. The drug works by blocking enzymes that help cancer cells grow. The goal is to see if it can shrink tumors and control the disease.

This study tests whether a smartphone app designed for people with HIV can help them quit smoking when they also get a lung cancer screening scan. About 100 participants will use the app and have a low-dose CT scan. The goal is to see if this approach is practical and helps peopl…

This study looks at whether it's possible to run a larger research project on surgery for a type of eye cancer (OSSN) in people living with HIV in Sub-Saharan Africa. About 84 participants will have the suspicious eye growth removed and be checked for up to a year. The goal is to…